KRAS and neoplasm: Interestingly, in CRC cell lines, the tumor-suppressing function of ODC depends on KRAS mutations, as neither loss- nor gain-of-function of ODC affects proliferation or migration in the KRAS wild-type Caco-2 cell line, both in vitro and in vivo [101].